In AI-based drug discovery—a field benefiting from a cumulative investment of $60 billion—the leaders are making real progress toward approved therapies.
The post Ten Companies to Watch in AI Drug Discovery appeared first on GEN – Genetic Engineering and Biotechnology News.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
